CONCLUSIONS
AR plays pivotal roles in prostate cancer, especially in the development of CRPC and the acquisition of resistance to AR-directed therapy. Even after the development of new AR-targeted therapy, CRPC will eventually gain resistance. Understanding the mechanisms of this resistance...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.